Archives:Category: Publications

National Academies of Sciences: Communicating COVID-19 Vaccine Efficacy and Effectiveness

The post below originally appeared in the National Academies of Sciences, Engineering and Medicine website and includes two guidance documents from the Societal Experts Action Networks (SEAN). The guidance includes 1) Communicating Vaccine Efficacy and 2) Communicating About Efficacy and Effectiveness in the Context of Equity in the COVID-19 Vaccine Distribution. Dr. Scott Ratzan is […]

New England Journal of Medicine: Dr. Scott Ratzan on “Missing the Point — How Primary Care Can Overcome Covid-19 Vaccine ‘Hesitancy'”

This article, co-authored by Scott Ratzan, M.D., M.P.A., Eric C. Schneider, M.D., Hilary Hatch, Ph.D., and Joseph Cacchione, M.D., was published on May 5, 2021 in the New England Journal of Medicine. The original article, references, and figures/media can be found here. By the end of April 2021, the United States had fully vaccinated just under a third […]

Journal of Health Communication: Building Confidence to CONVINCE

This article was published on March 13, 2021 in the Journal of Health Communication and was co-authored by Heidi J. Larson, Nancy Lee, Kenneth H. Rabin, Lauren Rauh & Scott C. Ratzan. This paper describes the inception and evolution to date of CONVINCE – COVID-19 New Vaccine Information, Communication and Engagement – a rapidly expanding, […]

The Journal of Health Communication: Hesitant or Not? The Association of Age, Gender, and Education with Potential Acceptance of a COVID-19 Vaccine: A Country-level Analysis

This article was published in The Journal of Health Communication on March 13, 2021. It was co-authored by Jeffrey V. Lazarus, Katarzyna Wyka, Lauren Rauh, Kenneth Rabin, Scott Ratzan, Lawrence O. Gostin, Heidi J. Larson & Ayman El-Mohandes. As the SARS-CoV2 pandemic reaches a year of global spread and a new surge of infections ravages […]

Financial Times Op-Ed: Business can make a big difference in ending Covid

This op-ed by Dr. Scott Ratzan was originally published in the Financial Times on December 4, 2020. One day early next year, you may well turn on your smartphone and see the following message, or one like it, from the company that you work for. What would go through your mind after you read it? […]

The Conversation: COVID-19 – A global survey shows worrying signs of vaccine hesitancy

This article was published in The Conversation. It has been nine months since the World Health Organisation (WHO) declared the outbreak of COVID-19, caused by the SARS-CoV-2 virus, a “public health emergency of international concern”. Since then, more than 44 million cases have been recorded and over one million lives lost. Economic costs measure in […]

Nature Medicine: A global survey of potential acceptance of a COVID-19 vaccine

This article was published by Nature Medicine and co-authored by Jeffrey V. Lazarus, Scott C. Ratzan,  Adam Palayew, Lawrence O. Gostin, Heidi J. Larson, Kenneth Rabin, Spencer Kimball & Ayman El-Mohandes.  Abstract Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance […]

National Center for Biotechnology Information: A global survey to assess public perceptions of government responses to COVID-19 (COVID-SCORE-10)

This article was originally published by the National Library of Medicine’s National Center for Biotechnology Information on PubMed.gov and was co-authored by Jeffrey V Lazarus, Scott Ratzan, Adam Palayew, Francesco C Billari, Agnes Binagwaho, Spencer Kimball, Heidi J Larson, Alessia Melegaro, Kenneth Rabin, Trenton M White, Ayman El-Mohandes. Abstract Background: Understanding public perceptions of government responses […]

Harvard Business Review: Why Businesses Must Help Build Trust in a Covid-19 Vaccine

This article was published by the Harvard Business Review by Rebecca Weintraub, Julie Rosenberg, Kenneth Rabin and Scott C. Ratzan Vaccine experts around the world are justifiably concerned by the lack of scientific data on the “Sputnik V” vaccine for Covid-19 that Russia recently approved after less than two months of human testing on a non-randomized group of […]